"Buckley, C." . "24"^^ . "Zola, H." . . . "Z(AV0Z5052915)" . "Aasted, B." . "CD molekuly 2005: lidsk\u00E9 bun\u011B\u010Dn\u00E9 diferencia\u010Dn\u00ED antigeny"@cs . . "Drbal, Karel" . "Nicholson, I." . "CD molecules 2005: human cell differentiation molecules" . "Hart, D." . "Malavasi, F." . "514562" . "Mason, D." . "Simmons, P." . . "Boumsell, L." . . "Swart, B." . "Isacke, C." . "Olive, D." . "Leukocyty interaguj\u00ED se sv\u00FDm okol\u00EDm pomoc\u00ED povrchov\u00FDch glykoprotein\u016F a glykolipid\u016F. Protil\u00E1tky rozezn\u00E1vaj\u00EDc\u00ED tyto receptory jsou cenn\u00FDmi n\u00E1stroji pro jejich studium a tak\u00E9 pro diagnostick\u00E9 a terapeutick\u00E9 \u00FA\u010Dely. Posledn\u00ED, osm\u00FD workshop a konference o lidsk\u00FDch leukocyt\u00E1rn\u00EDch diferencia\u010Dn\u00EDch antigenech (Adelaide, prosinec 2004) zavedla 95 nov\u00FDch CD n\u00E1zv\u016F a u\u010Dinila radik\u00E1ln\u00ED zm\u011Bny v budouc\u00EDch c\u00EDlech a opera\u010Dn\u00ED strategii t\u011Bchto mezin\u00E1rodn\u00EDch akc\u00ED tak, aby udr\u017Eela jejich v\u00FDznam pro modern\u00ED biologii a klinickou praxi."@cs . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Clark, G." . . "Schlossman, S. F." . "CD molecules 2005: human cell differentiation molecules"@en . "Uguccioni, M." . "RIV/68378050:_____/05:00027595!RIV06-AV0-68378050" . . "Warren, H." . . "Schwartz-Albiez, R." . "Saalm\u00FCller, A." . . . "RIV/68378050:_____/05:00027595" . "2"^^ . . "106" . "0006-4971" . "3123;3126" . "Leukocytes interact with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules are powerful tools for analysis of their structure, function, and distribution. Antibodies have been used in research, diagnosis, and therapy. The CD nomenclature provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice." . . "[CE60F7FAAC0F]" . "CD molekuly 2005: lidsk\u00E9 bun\u011B\u010Dn\u00E9 diferencia\u010Dn\u00ED antigeny"@cs . "CD molecules 2005: human cell differentiation molecules"@en . "Leukocytes interact with each other, with other cells, with tissue matrices, with infectious agents, and with other antigens. These interactions are mediated by cell-surface glycoproteins and glycolipids. Antibodies against these leukocyte molecules are powerful tools for analysis of their structure, function, and distribution. Antibodies have been used in research, diagnosis, and therapy. The CD nomenclature provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), held in Adelaide, Australia, in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice."@en . "CD molecules; leukocyte antigen"@en . "Ho\u0159ej\u0161\u00ED, V\u00E1clav" . "CD molecules 2005: human cell differentiation molecules" . "Blood" . "Macardle, P." . . "Engel, P." . "9" . "4"^^ . "Bensussan, A." . "Tedder, T. F." . . .